LFWD Stock Falls Despite Launch of Next-Generation Mobility ReWalk 7

Lifeward Ltd. (LFWD) recently launched the ReWalk 7 Personal Exoskeleton in the U.S. market, marking another milestone in assistive technology for individuals with spinal cord injuries. This seventh-generation device builds on Lifeward’s extensive experience and industry leadership, featuring a host of new technological advancements that enhance user independence and functionality.The ReWalk 7, which received FDA clearance in March 2025, follows earlier innovations introduced with the ReWalk 6.0 system, whi ...